AVRO | AVROBIO, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	N/A - N/A
52 Week Range	N/A - N/A
Beta	1.50
Implied Volatility	403.89%
IV Rank	100.00%
Day's Volume	N/A
Average Volume	N/A
Shares Outstanding	N/A
Market Cap	N/A
Sector	Healthcare
Industry	Biotechnology
IPO Date	2018-06-21

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	N/A
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	13
Country	USA
Website	AVRO

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

AVRO's peers: ABCL, ABSI, ACHV, ADPT, AKBA, ALT, ANNX, ARDX, ATOS, AVIR, BNTX, CELU, CNSP, CRSP, CYCCP, DNA, DRMA, ELEV, ENVB, FGEN, GERN, HEPA, IMMP, IMMX, INO, LPCN, LXRX, MRNA, NBTX, NBY, OCGN, ORMP, PDSB, PHAT, PHIO, RAIN, RCUS, RXRX, VKTX, CDIO, SPRY, ZVSA, OCEA, CARM

*Chart delayed

Analyzing fundamentals for AVRO we got that it has average fundamentals where Valuation is considered to be fairly valued, Profitability is stunning wealthy, Growth is very bad and Health is weak. For more detailed analysis please see AVRO Fundamentals page.

Watching at AVRO technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on AVRO Technicals page.